 | • レポートコード：MRC2Q12-19188 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、リポソーム注射の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にリポソーム注射のグローバル市場のxxx％を占める「ドキソルビシン塩酸塩リポソーム注」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「悪性腫瘍治療薬」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 リポソーム注射の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのリポソーム注射市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 リポソーム注射のグローバル主要プレイヤーには、CSPC、Luye Pharma、Fudan Zhangjiang、Nanjing Cisco、Qilu Pharmaceutical、Sichuan Kelun、Modern Medicine、Eudinamis、Indiamart、Getwelloncology、Polymunなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 リポソーム注射市場は、種類と用途によって区分されます。世界のリポソーム注射市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 ドキソルビシン塩酸塩リポソーム注、ミトキサントロン塩酸塩リポソーム注、イリノテカン塩酸塩リポソーム注、その他 【用途別セグメント】 悪性腫瘍治療薬、感染症治療薬、術後疼痛緩和薬、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - リポソーム注射製品概要 - 種類別市場（ドキソルビシン塩酸塩リポソーム注、ミトキサントロン塩酸塩リポソーム注、イリノテカン塩酸塩リポソーム注、その他） - 用途別市場（悪性腫瘍治療薬、感染症治療薬、術後疼痛緩和薬、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のリポソーム注射販売量予測2017-2028 - 世界のリポソーム注射売上予測2017-2028 - リポソーム注射の地域別販売量 - リポソーム注射の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別リポソーム注射販売量 - 主要メーカー別リポソーム注射売上 - 主要メーカー別リポソーム注射価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（ドキソルビシン塩酸塩リポソーム注、ミトキサントロン塩酸塩リポソーム注、イリノテカン塩酸塩リポソーム注、その他） - リポソーム注射の種類別販売量 - リポソーム注射の種類別売上 - リポソーム注射の種類別価格 ・用途別市場規模（悪性腫瘍治療薬、感染症治療薬、術後疼痛緩和薬、その他） - リポソーム注射の用途別販売量 - リポソーム注射の用途別売上 - リポソーム注射の用途別価格 ・北米市場 - 北米のリポソーム注射市場規模（種類別、用途別） - 主要国別のリポソーム注射市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのリポソーム注射市場規模（種類別、用途別） - 主要国別のリポソーム注射市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のリポソーム注射市場規模（種類別、用途別） - 主要国別のリポソーム注射市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のリポソーム注射市場規模（種類別、用途別） - 主要国別のリポソーム注射市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのリポソーム注射市場規模（種類別、用途別） - 主要国別のリポソーム注射市場規模（トルコ、サウジアラビア） ・企業情報 CSPC、Luye Pharma、Fudan Zhangjiang、Nanjing Cisco、Qilu Pharmaceutical、Sichuan Kelun、Modern Medicine、Eudinamis、Indiamart、Getwelloncology、Polymun ・産業チェーン及び販売チャネル分析 - リポソーム注射の産業チェーン分析 - リポソーム注射の原材料 - リポソーム注射の生産プロセス - リポソーム注射の販売及びマーケティング - リポソーム注射の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - リポソーム注射の産業動向 - リポソーム注射のマーケットドライバー - リポソーム注射の課題 - リポソーム注射の阻害要因 ・主な調査結果 |
Liposomes are lipid microcapsules composed of an amphiphilic lipid bilayer (monolayer) and/or a series of concentric discontinuous aqueous compartments separated by a series of multiple amphiphilic bilayers. In liposome drugs, the drug is contained in liposomes. In general, water-soluble drugs are often encapsulated in the aqueous compartment, and lipophilic drugs are encapsulated in the lipid bilayer of the liposome.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Liposome Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Liposome Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Liposome Injection is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Liposome Injection include CSPC, Luye Pharma, Fudan Zhangjiang, Nanjing Cisco, Qilu Pharmaceutical, Sichuan Kelun, Modern Medicine, Eudinamis and Indiamart, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Liposome Injection manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Liposome Injection market. Further, it explains the major drivers and regional dynamics of the global Liposome Injection market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
CSPC
Luye Pharma
Fudan Zhangjiang
Nanjing Cisco
Qilu Pharmaceutical
Sichuan Kelun
Modern Medicine
Eudinamis
Indiamart
Getwelloncology
Polymun
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Liposome Injection Segment by Type
Doxorubicin Hydrochloride Liposome Injection
Mitoxantrone Hydrochloride Liposome Injection
Irinotecan Hydrochloride Liposome Injection
Others
Liposome Injection Segment by Application
Malignant Tumor Treatment
Infection Treatment
Post-operative Pain Relief
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Liposome Injection market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Liposome Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Liposome Injection, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Liposome Injection, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Liposome Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Liposome Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Liposome Injection sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CSPC, Luye Pharma, Fudan Zhangjiang, Nanjing Cisco, Qilu Pharmaceutical, Sichuan Kelun, Modern Medicine, Eudinamis and Indiamart, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Liposome Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Liposome Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Liposome Injection sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Liposome Injection Product Introduction
1.2 Market by Type
1.2.1 Global Liposome Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Doxorubicin Hydrochloride Liposome Injection
1.2.3 Mitoxantrone Hydrochloride Liposome Injection
1.2.4 Irinotecan Hydrochloride Liposome Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Liposome Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Malignant Tumor Treatment
1.3.3 Infection Treatment
1.3.4 Post-operative Pain Relief
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Liposome Injection Sales Estimates and Forecasts 2017-2028
2.2 Global Liposome Injection Revenue Estimates and Forecasts 2017-2028
2.3 Global Liposome Injection Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Liposome Injection Sales by Region
2.4.1 Global Liposome Injection Sales by Region (2017-2022)
2.4.2 Global Sales Liposome Injection by Region (2023-2028)
2.5 Global Liposome Injection Revenue by Region
2.5.1 Global Liposome Injection Revenue by Region (2017-2022)
2.5.2 Global Liposome Injection Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Liposome Injection Sales by Manufacturers
3.1.1 Global Top Liposome Injection Manufacturers by Sales (2017-2022)
3.1.2 Global Liposome Injection Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Liposome Injection in 2021
3.2 Global Liposome Injection Revenue by Manufacturers
3.2.1 Global Liposome Injection Revenue by Manufacturers (2017-2022)
3.2.2 Global Liposome Injection Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Liposome Injection Revenue in 2021
3.3 Global Liposome Injection Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Liposome Injection Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Liposome Injection Sales by Type
4.1.1 Global Liposome Injection Historical Sales by Type (2017-2022)
4.1.2 Global Liposome Injection Forecasted Sales by Type (2023-2028)
4.1.3 Global Liposome Injection Sales Market Share by Type (2017-2028)
4.2 Global Liposome Injection Revenue by Type
4.2.1 Global Liposome Injection Historical Revenue by Type (2017-2022)
4.2.2 Global Liposome Injection Forecasted Revenue by Type (2023-2028)
4.2.3 Global Liposome Injection Revenue Market Share by Type (2017-2028)
4.3 Global Liposome Injection Price by Type
4.3.1 Global Liposome Injection Price by Type (2017-2022)
4.3.2 Global Liposome Injection Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Liposome Injection Sales by Application
5.1.1 Global Liposome Injection Historical Sales by Application (2017-2022)
5.1.2 Global Liposome Injection Forecasted Sales by Application (2023-2028)
5.1.3 Global Liposome Injection Sales Market Share by Application (2017-2028)
5.2 Global Liposome Injection Revenue by Application
5.2.1 Global Liposome Injection Historical Revenue by Application (2017-2022)
5.2.2 Global Liposome Injection Forecasted Revenue by Application (2023-2028)
5.2.3 Global Liposome Injection Revenue Market Share by Application (2017-2028)
5.3 Global Liposome Injection Price by Application
5.3.1 Global Liposome Injection Price by Application (2017-2022)
5.3.2 Global Liposome Injection Price Forecast by Application (2023-2028)
6 North America
6.1 North America Liposome Injection Market Size by Type
6.1.1 North America Liposome Injection Sales by Type (2017-2028)
6.1.2 North America Liposome Injection Revenue by Type (2017-2028)
6.2 North America Liposome Injection Market Size by Application
6.2.1 North America Liposome Injection Sales by Application (2017-2028)
6.2.2 North America Liposome Injection Revenue by Application (2017-2028)
6.3 North America Liposome Injection Market Size by Country
6.3.1 North America Liposome Injection Sales by Country (2017-2028)
6.3.2 North America Liposome Injection Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Liposome Injection Market Size by Type
7.1.1 Europe Liposome Injection Sales by Type (2017-2028)
7.1.2 Europe Liposome Injection Revenue by Type (2017-2028)
7.2 Europe Liposome Injection Market Size by Application
7.2.1 Europe Liposome Injection Sales by Application (2017-2028)
7.2.2 Europe Liposome Injection Revenue by Application (2017-2028)
7.3 Europe Liposome Injection Market Size by Country
7.3.1 Europe Liposome Injection Sales by Country (2017-2028)
7.3.2 Europe Liposome Injection Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Liposome Injection Market Size by Type
8.1.1 Asia Pacific Liposome Injection Sales by Type (2017-2028)
8.1.2 Asia Pacific Liposome Injection Revenue by Type (2017-2028)
8.2 Asia Pacific Liposome Injection Market Size by Application
8.2.1 Asia Pacific Liposome Injection Sales by Application (2017-2028)
8.2.2 Asia Pacific Liposome Injection Revenue by Application (2017-2028)
8.3 Asia Pacific Liposome Injection Market Size by Region
8.3.1 Asia Pacific Liposome Injection Sales by Region (2017-2028)
8.3.2 Asia Pacific Liposome Injection Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Liposome Injection Market Size by Type
9.1.1 Latin America Liposome Injection Sales by Type (2017-2028)
9.1.2 Latin America Liposome Injection Revenue by Type (2017-2028)
9.2 Latin America Liposome Injection Market Size by Application
9.2.1 Latin America Liposome Injection Sales by Application (2017-2028)
9.2.2 Latin America Liposome Injection Revenue by Application (2017-2028)
9.3 Latin America Liposome Injection Market Size by Country
9.3.1 Latin America Liposome Injection Sales by Country (2017-2028)
9.3.2 Latin America Liposome Injection Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Liposome Injection Market Size by Type
10.1.1 Middle East and Africa Liposome Injection Sales by Type (2017-2028)
10.1.2 Middle East and Africa Liposome Injection Revenue by Type (2017-2028)
10.2 Middle East and Africa Liposome Injection Market Size by Application
10.2.1 Middle East and Africa Liposome Injection Sales by Application (2017-2028)
10.2.2 Middle East and Africa Liposome Injection Revenue by Application (2017-2028)
10.3 Middle East and Africa Liposome Injection Market Size by Country
10.3.1 Middle East and Africa Liposome Injection Sales by Country (2017-2028)
10.3.2 Middle East and Africa Liposome Injection Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 CSPC
11.1.1 CSPC Corporation Information
11.1.2 CSPC Overview
11.1.3 CSPC Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 CSPC Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 CSPC Recent Developments
11.2 Luye Pharma
11.2.1 Luye Pharma Corporation Information
11.2.2 Luye Pharma Overview
11.2.3 Luye Pharma Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Luye Pharma Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Luye Pharma Recent Developments
11.3 Fudan Zhangjiang
11.3.1 Fudan Zhangjiang Corporation Information
11.3.2 Fudan Zhangjiang Overview
11.3.3 Fudan Zhangjiang Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Fudan Zhangjiang Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Fudan Zhangjiang Recent Developments
11.4 Nanjing Cisco
11.4.1 Nanjing Cisco Corporation Information
11.4.2 Nanjing Cisco Overview
11.4.3 Nanjing Cisco Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nanjing Cisco Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nanjing Cisco Recent Developments
11.5 Qilu Pharmaceutical
11.5.1 Qilu Pharmaceutical Corporation Information
11.5.2 Qilu Pharmaceutical Overview
11.5.3 Qilu Pharmaceutical Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Qilu Pharmaceutical Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Qilu Pharmaceutical Recent Developments
11.6 Sichuan Kelun
11.6.1 Sichuan Kelun Corporation Information
11.6.2 Sichuan Kelun Overview
11.6.3 Sichuan Kelun Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Sichuan Kelun Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sichuan Kelun Recent Developments
11.7 Modern Medicine
11.7.1 Modern Medicine Corporation Information
11.7.2 Modern Medicine Overview
11.7.3 Modern Medicine Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Modern Medicine Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Modern Medicine Recent Developments
11.8 Eudinamis
11.8.1 Eudinamis Corporation Information
11.8.2 Eudinamis Overview
11.8.3 Eudinamis Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Eudinamis Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Eudinamis Recent Developments
11.9 Indiamart
11.9.1 Indiamart Corporation Information
11.9.2 Indiamart Overview
11.9.3 Indiamart Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Indiamart Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Indiamart Recent Developments
11.10 Getwelloncology
11.10.1 Getwelloncology Corporation Information
11.10.2 Getwelloncology Overview
11.10.3 Getwelloncology Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Getwelloncology Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Getwelloncology Recent Developments
11.11 Polymun
11.11.1 Polymun Corporation Information
11.11.2 Polymun Overview
11.11.3 Polymun Liposome Injection Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Polymun Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Polymun Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Liposome Injection Industry Chain Analysis
12.2 Liposome Injection Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Liposome Injection Production Mode & Process
12.4 Liposome Injection Sales and Marketing
12.4.1 Liposome Injection Sales Channels
12.4.2 Liposome Injection Distributors
12.5 Liposome Injection Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Liposome Injection Industry Trends
13.2 Liposome Injection Market Drivers
13.3 Liposome Injection Market Challenges
13.4 Liposome Injection Market Restraints
14 Key Findings in The Global Liposome Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table 1. Global Liposome Injection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Doxorubicin Hydrochloride Liposome Injection
Table 3. Major Manufacturers of Mitoxantrone Hydrochloride Liposome Injection
Table 4. Major Manufacturers of Irinotecan Hydrochloride Liposome Injection
Table 5. Major Manufacturers of Others
Table 6. Global Liposome Injection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Liposome Injection Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Liposome Injection Sales by Region (2017-2022) & (K Units)
Table 9. Global Liposome Injection Sales Market Share by Region (2017-2022)
Table 10. Global Liposome Injection Sales by Region (2023-2028) & (K Units)
Table 11. Global Liposome Injection Sales Market Share by Region (2023-2028)
Table 12. Global Liposome Injection Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Liposome Injection Revenue Market Share by Region (2017-2022)
Table 14. Global Liposome Injection Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Liposome Injection Revenue Market Share by Region (2023-2028)
Table 16. Global Liposome Injection Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Liposome Injection Sales Share by Manufacturers (2017-2022)
Table 18. Global Liposome Injection Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Liposome Injection Revenue Share by Manufacturers (2017-2022)
Table 20. Liposome Injection Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Liposome Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Liposome Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposome Injection as of 2021)
Table 23. Liposome Injection Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Liposome Injection Product Offered
Table 25. Date of Manufacturers Enter into Liposome Injection Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Liposome Injection Sales by Type (2017-2022) & (K Units)
Table 28. Global Liposome Injection Sales by Type (2023-2028) & (K Units)
Table 29. Global Liposome Injection Sales Share by Type (2017-2022)
Table 30. Global Liposome Injection Sales Share by Type (2023-2028)
Table 31. Global Liposome Injection Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Liposome Injection Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Liposome Injection Revenue Share by Type (2017-2022)
Table 34. Global Liposome Injection Revenue Share by Type (2023-2028)
Table 35. Liposome Injection Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Liposome Injection Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Liposome Injection Sales by Application (2017-2022) & (K Units)
Table 38. Global Liposome Injection Sales by Application (2023-2028) & (K Units)
Table 39. Global Liposome Injection Sales Share by Application (2017-2022)
Table 40. Global Liposome Injection Sales Share by Application (2023-2028)
Table 41. Global Liposome Injection Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Liposome Injection Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Liposome Injection Revenue Share by Application (2017-2022)
Table 44. Global Liposome Injection Revenue Share by Application (2023-2028)
Table 45. Liposome Injection Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Liposome Injection Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Liposome Injection Sales by Type (2017-2022) & (K Units)
Table 48. North America Liposome Injection Sales by Type (2023-2028) & (K Units)
Table 49. North America Liposome Injection Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Liposome Injection Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Liposome Injection Sales by Application (2017-2022) & (K Units)
Table 52. North America Liposome Injection Sales by Application (2023-2028) & (K Units)
Table 53. North America Liposome Injection Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Liposome Injection Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Liposome Injection Sales by Country (2017-2022) & (K Units)
Table 56. North America Liposome Injection Sales by Country (2023-2028) & (K Units)
Table 57. North America Liposome Injection Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Liposome Injection Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Liposome Injection Sales by Type (2017-2022) & (K Units)
Table 60. Europe Liposome Injection Sales by Type (2023-2028) & (K Units)
Table 61. Europe Liposome Injection Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Liposome Injection Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Liposome Injection Sales by Application (2017-2022) & (K Units)
Table 64. Europe Liposome Injection Sales by Application (2023-2028) & (K Units)
Table 65. Europe Liposome Injection Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Liposome Injection Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Liposome Injection Sales by Country (2017-2022) & (K Units)
Table 68. Europe Liposome Injection Sales by Country (2023-2028) & (K Units)
Table 69. Europe Liposome Injection Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Liposome Injection Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Liposome Injection Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Liposome Injection Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Liposome Injection Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Liposome Injection Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Liposome Injection Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Liposome Injection Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Liposome Injection Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Liposome Injection Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Liposome Injection Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Liposome Injection Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Liposome Injection Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Liposome Injection Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Liposome Injection Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Liposome Injection Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Liposome Injection Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Liposome Injection Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Liposome Injection Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Liposome Injection Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Liposome Injection Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Liposome Injection Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Liposome Injection Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Liposome Injection Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Liposome Injection Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Liposome Injection Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Liposome Injection Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Liposome Injection Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Liposome Injection Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Liposome Injection Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Liposome Injection Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Liposome Injection Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Liposome Injection Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Liposome Injection Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Liposome Injection Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Liposome Injection Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Liposome Injection Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Liposome Injection Revenue by Country (2023-2028) & (US$ Million)
Table 107. CSPC Corporation Information
Table 108. CSPC Description and Major Businesses
Table 109. CSPC Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. CSPC Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. CSPC Recent Developments
Table 112. Luye Pharma Corporation Information
Table 113. Luye Pharma Description and Major Businesses
Table 114. Luye Pharma Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Luye Pharma Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Luye Pharma Recent Developments
Table 117. Fudan Zhangjiang Corporation Information
Table 118. Fudan Zhangjiang Description and Major Businesses
Table 119. Fudan Zhangjiang Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. Fudan Zhangjiang Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Fudan Zhangjiang Recent Developments
Table 122. Nanjing Cisco Corporation Information
Table 123. Nanjing Cisco Description and Major Businesses
Table 124. Nanjing Cisco Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Nanjing Cisco Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Nanjing Cisco Recent Developments
Table 127. Qilu Pharmaceutical Corporation Information
Table 128. Qilu Pharmaceutical Description and Major Businesses
Table 129. Qilu Pharmaceutical Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Qilu Pharmaceutical Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Qilu Pharmaceutical Recent Developments
Table 132. Sichuan Kelun Corporation Information
Table 133. Sichuan Kelun Description and Major Businesses
Table 134. Sichuan Kelun Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Sichuan Kelun Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sichuan Kelun Recent Developments
Table 137. Modern Medicine Corporation Information
Table 138. Modern Medicine Description and Major Businesses
Table 139. Modern Medicine Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Modern Medicine Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Modern Medicine Recent Developments
Table 142. Eudinamis Corporation Information
Table 143. Eudinamis Description and Major Businesses
Table 144. Eudinamis Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Eudinamis Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Eudinamis Recent Developments
Table 147. Indiamart Corporation Information
Table 148. Indiamart Description and Major Businesses
Table 149. Indiamart Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Indiamart Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Indiamart Recent Developments
Table 152. Getwelloncology Corporation Information
Table 153. Getwelloncology Description and Major Businesses
Table 154. Getwelloncology Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Getwelloncology Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Getwelloncology Recent Developments
Table 157. Polymun Corporation Information
Table 158. Polymun Description and Major Businesses
Table 159. Polymun Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Polymun Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Polymun Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Liposome Injection Distributors List
Table 165. Liposome Injection Customers List
Table 166. Liposome Injection Market Trends
Table 167. Liposome Injection Market Drivers
Table 168. Liposome Injection Market Challenges
Table 169. Liposome Injection Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Liposome Injection Product Picture
Figure 2. Global Liposome Injection Market Share by Type in 2021 & 2028
Figure 3. Doxorubicin Hydrochloride Liposome Injection Product Picture
Figure 4. Mitoxantrone Hydrochloride Liposome Injection Product Picture
Figure 5. Irinotecan Hydrochloride Liposome Injection Product Picture
Figure 6. Others Product Picture
Figure 7. Global Liposome Injection Market Share by Application in 2021 & 2028
Figure 8. Malignant Tumor Treatment
Figure 9. Infection Treatment
Figure 10. Post-operative Pain Relief
Figure 11. Others
Figure 12. Liposome Injection Report Years Considered
Figure 13. Global Liposome Injection Sales 2017-2028 (K Units)
Figure 14. Global Liposome Injection Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Liposome Injection Revenue 2017-2028 (US$ Million)
Figure 16. Global Liposome Injection Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Liposome Injection Sales Market Share by Region (2017-2022)
Figure 18. Global Liposome Injection Sales Market Share by Region (2023-2028)
Figure 19. North America Liposome Injection Sales YoY (2017-2028) & (K Units)
Figure 20. North America Liposome Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Liposome Injection Sales YoY (2017-2028) & (K Units)
Figure 22. Europe Liposome Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Liposome Injection Sales YoY (2017-2028) & (K Units)
Figure 24. Asia-Pacific Liposome Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Liposome Injection Sales YoY (2017-2028) & (K Units)
Figure 26. Latin America Liposome Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Liposome Injection Sales YoY (2017-2028) & (K Units)
Figure 28. Middle East & Africa Liposome Injection Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Liposome Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Liposome Injection in the World: Market Share by Liposome Injection Revenue in 2021
Figure 31. Global Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Liposome Injection Sales Market Share by Type (2017-2028)
Figure 33. Global Liposome Injection Revenue Market Share by Type (2017-2028)
Figure 34. Global Liposome Injection Sales Market Share by Application (2017-2028)
Figure 35. Global Liposome Injection Revenue Market Share by Application (2017-2028)
Figure 36. North America Liposome Injection Sales Market Share by Type (2017-2028)
Figure 37. North America Liposome Injection Revenue Market Share by Type (2017-2028)
Figure 38. North America Liposome Injection Sales Market Share by Application (2017-2028)
Figure 39. North America Liposome Injection Revenue Market Share by Application (2017-2028)
Figure 40. North America Liposome Injection Sales Share by Country (2017-2028)
Figure 41. North America Liposome Injection Revenue Share by Country (2017-2028)
Figure 42. United States Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Liposome Injection Sales Market Share by Type (2017-2028)
Figure 45. Europe Liposome Injection Revenue Market Share by Type (2017-2028)
Figure 46. Europe Liposome Injection Sales Market Share by Application (2017-2028)
Figure 47. Europe Liposome Injection Revenue Market Share by Application (2017-2028)
Figure 48. Europe Liposome Injection Sales Share by Country (2017-2028)
Figure 49. Europe Liposome Injection Revenue Share by Country (2017-2028)
Figure 50. Germany Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 51. France Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Liposome Injection Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Liposome Injection Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Liposome Injection Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Liposome Injection Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Liposome Injection Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Liposome Injection Revenue Share by Region (2017-2028)
Figure 61. China Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 64. India Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 66. China Taiwan Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Liposome Injection Sales Market Share by Type (2017-2028)
Figure 71. Latin America Liposome Injection Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Liposome Injection Sales Market Share by Application (2017-2028)
Figure 73. Latin America Liposome Injection Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Liposome Injection Sales Share by Country (2017-2028)
Figure 75. Latin America Liposome Injection Revenue Share by Country (2017-2028)
Figure 76. Mexico Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 77. Brazil Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 78. Argentina Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 79. Colombia Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Liposome Injection Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Liposome Injection Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Liposome Injection Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Liposome Injection Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Liposome Injection Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Liposome Injection Revenue Share by Country (2017-2028)
Figure 86. Turkey Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 88. UAE Liposome Injection Revenue (2017-2028) & (US$ Million)
Figure 89. Liposome Injection Value Chain
Figure 90. Liposome Injection Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed